SRPT
Sarepta Therapeutics Inc. Healthcare - Biotechnology Investor Relations →
Sarepta Therapeutics Inc. (SRPT) closed at $16.69 as of 2026-03-20, trading 82.1% below its 200-week moving average of $93.38. This places SRPT in the extreme value zone. The stock moved further from the line this week, up from -82.5% last week. The 14-week RSI sits at 34, indicating neutral momentum.
Trading volume is running at 1.0x of its 14-week average, which is in the normal range. The balance between buying and selling volume (0.77 ratio) is neutral — neither side is clearly dominating.
Over the past 1454 weeks of data, SRPT has crossed below its 200-week moving average 22 times. On average, these episodes lasted 36 weeks. Historically, investors who bought SRPT at the start of these episodes saw an average one-year return of +34.2%.
With a market cap of $1752 million, SRPT is a small-cap stock. The company generates a free cash flow yield of 5.5%, which is healthy. Return on equity stands at -53.5%. The stock trades at 1.5x book value.
Share count has increased 19.3% over three years, indicating dilution. This stock also meets the Yartseva multibagger criteria as a small-cap with strong free cash flow yield and reasonable book value.
Over the past 27.9 years, a hypothetical investment of $100 in SRPT would have grown to $40, compared to $967 for the S&P 500. SRPT has returned -3.3% annualized vs 8.5% for the index, underperforming the broader market over this period.
Free cash flow has been volatile over the past several years, making the quality of earnings harder to assess.
Business Health
Annual financials — how the underlying business has performed over the past several years.
Cash Flow Free cash flow & net income ($M)
Revenue Annual revenue ($M) — business growth proxy
Total Debt Balance sheet debt ($M)
ROIC Return on invested capital (%)
FCF Yield Free cash flow / market cap (%) — Yartseva signal
Gross Margin Pricing power & competitive moat (%)
Shares Outstanding Buybacks vs dilution (millions)
Growth of $100: SRPT vs S&P 500
Monthly data normalized to $100 at start. Vertical dashed lines mark 200-week MA touches.
What Happens After SRPT Crosses Below the Line?
Across 22 historical episodes, buying SRPT when it crossed below its 200-week moving average produced an average return of +25.9% after 12 months (median -1.0%), compared to +8.7% for the S&P 500 over the same periods. 41% of those episodes were profitable after one year. After 24 months, the average return was +96.8% vs +14.8% for the index.
Each line shows $100 invested at the moment SRPT crossed below its 200-week MA. Bold blue = stock average. Gray dashed = S&P 500 average over same periods.
Historical Touches
SRPT has crossed below its 200-week MA 22 times with an average 1-year return of +34.2% after recovery.
| Crossed Below | Recovered | Weeks | Max Depth | 1-Year Return | Return Since Touch |
|---|---|---|---|---|---|
| May 1998 | Nov 1999 | 77 | 57.7% | -38.6% | -57.6% |
| Dec 1999 | Dec 1999 | 1 | 4.4% | +33.3% | -45.1% |
| Jul 2000 | Jul 2000 | 1 | 4.0% | +39.7% | -56.6% |
| Oct 2000 | Apr 2001 | 30 | 40.7% | +17.1% | -55.9% |
| Apr 2002 | Apr 2002 | 1 | 0.5% | -47.4% | -60.1% |
| May 2002 | Jan 2006 | 191 | 71.8% | -5.6% | -52.5% |
| Jun 2006 | Aug 2006 | 10 | 33.2% | -23.1% | -28.5% |
| Sep 2006 | Oct 2006 | 5 | 7.1% | -24.0% | -21.4% |
| Nov 2006 | Jul 2010 | 191 | 83.3% | -35.1% | -22.5% |
| Mar 2011 | Apr 2011 | 1 | 4.0% | -0.6% | +79.5% |
| Jun 2011 | Jul 2011 | 4 | 13.3% | -48.9% | +106.0% |
| Jul 2011 | Mar 2012 | 33 | 60.4% | -4.1% | +89.2% |
| Apr 2012 | Jul 2012 | 16 | 55.4% | +497.5% | +175.4% |
| Nov 2013 | Nov 2013 | 2 | 10.0% | +6.7% | +16.1% |
| Oct 2014 | Oct 2014 | 1 | 3.9% | +97.6% | -11.1% |
| Oct 2014 | May 2015 | 29 | 39.4% | +48.8% | +3.2% |
| Jan 2016 | Aug 2016 | 32 | 51.8% | +164.9% | +16.9% |
| Jan 2021 | Aug 2022 | 83 | 43.9% | +3.9% | -79.7% |
| Oct 2022 | Nov 2022 | 2 | 3.2% | -24.7% | -83.9% |
| Jul 2023 | Aug 2023 | 3 | 1.9% | +37.5% | -84.2% |
| Oct 2023 | Jan 2024 | 11 | 27.7% | +22.8% | -84.4% |
| Feb 2025 | Ongoing | 57+ | 88.5% | Ongoing | -84.3% |
| Average | 36 | — | +34.2% | — |
Frequently Asked Questions
Is SRPT below its 200-week moving average?
Yes. As of 2026-03-20, Sarepta Therapeutics Inc. (SRPT) is trading 82.1% below its 200-week moving average of $93.38. The current price is $16.69.
What is SRPT's 200-week moving average price?
Sarepta Therapeutics Inc.'s 200-week moving average is $93.38 as of 2026-03-20. This is the average weekly closing price over roughly the last 4 years, and it acts as a long-term trend line. When a stock drops below this level, it can signal that the price has fallen far enough from the long-term trend to attract value-oriented investors.
What happens when SRPT drops below its 200-week moving average?
SRPT has crossed below its 200-week moving average 22 times in our data. On average, buying at that moment produced a one-year return of +34.2%. These dips have historically been decent entry points. These episodes lasted 36 weeks on average.
Is SRPT a good value right now?
Here's what our data says about SRPT as of 2026-03-20: The stock is below its 200-week moving average, which is the starting point for our analysis. The 14-week RSI is 34. Free cash flow yield is 5.5%. Return on equity is -53.5%. Price-to-book is 1.5x. This is not a buy or sell recommendation — always do your own research.
How does SRPT compare to the S&P 500?
Over the past 27.9 years, $100 invested in SRPT would have grown to $40, compared to $967 for the S&P 500. That's -3.3% annualized vs 8.5% for the index. SRPT has underperformed the broader market over this period.
Not financial advice. This is an educational tool. Past performance does not guarantee future results. Do your own research before making investment decisions.
Data as of week of 2026-03-20